Proposed Brexit Agreement / LS Law

Join us on the 12th April for our live webinar! Marketing of Pharmaceutical Drugs & Interactions with Healthcare Professionals in a Digital Era.

Find out more

28th December 2020

The 1,246 page proposed Brexit agreement announced on Christmas Eve, has left an unsettled churn in my stomach.

What are its implications for businesses and LS Law clients?

The import and export of most goods within the EU without tariffs, has in the main been retained, but Customs paperwork will be more time consuming, and the European Courts of Justice no longer have automatic sovereignty over agreements and disputes.

What bearing does this have on existing cross-border contracts, supply chain, manufacturing, and trade agreements generally?

How will this affect the way in which you negotiate new deals and promote your services?

There are specific provisions governing healthcare, pharmaceuticals, animal health and professional services.

Watch this space for further updates relevant to the Lifesciences industry on the proposed Brexit deal and the solutions on how to navigate its ramifications.

Blogs

Proposed Brexit Agreement